BMRN FY 2011 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena

BMRNBioMarin Pharmaceutical Inc.

$11B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$441M+17.3% YoY

Gross Profit

$357M81.0% margin

Operating Income

-$34M-7.7% margin

Net Income

-$54M-12.2% margin

EPS (Diluted)

$-0.48

Cash Flow

Operating Cash Flow

$19M

Free Cash Flow

-$135M

Stock-Based Comp.

$44M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$533M

Stockholders' Equity

$773M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$441M	$376M	+17.3%
Gross Profit	$357M	$306M	+16.8%
Operating Income	-$34M	$544,000	-6329.8%
Net Income	-$54M	$206M	-126.2%